Survey Reveals African Hesitancy to Get Mpox Vaccination

Image credit: Road Ahead, Unsplash A new survey conducted amongst Africans across 6 countries found that 32.7% of respondents were hesitant to get vaccinated against mpox and for those who were parents, 38.9% were hesitant to get their children vaccinated.1 The results of the survey were published in eClinicalMedicine. “The weighted rates of mpox vaccination […]

Nirmatrelvir-Ritonavir (Paxlovid) Reduces Short and Long-Term Adverse Outcomes in COVID-19 Patients with Kidney Disease

Close up of the antiviral by Pfizer, Paxlovid. Image credits: Unsplash A recent study published in Open Forum Infectious Diseases demonstrates that nirmatrelvir-ritonavir (Paxlovid), an antiviral treatment for COVID-19, significantly reduces short- and long-term adverse outcomes in patients with kidney disease. This cohort study involved 1,095 patients with kidney disease who received Paxlovid, compared to […]

Modeling tool affirms critical role of testing in pandemic response

The COVID-19 pandemic highlighted how crucial testing is for disease preparedness and response, and new research from the Johns Hopkins Applied Physics Laboratory (APL) and a team of collaborators underscores that principle. Published in the Jan. 2 edition of The Lancet Public Health, the research included simulation and analysis that suggests public-private partnerships to develop, […]

NIH Offers Updated Risk Assessment on Avian Influenza

Three influenza A (H5N1/bird flu) virus particles (rod-shaped; yellow). Note: Layout incorporates two CDC transmission electron micrographs that have been repositioned and colorized by NIAID. Image credit: CDC and NIAID The National Institutes of Health (NIH) updated its risk assessment for highly pathogenic H5N1 avian influenza A virus (HPAI H5N1) saying the risk to the […]

Updated Tuberculosis Treatment Guidelines

Different TB tests Image credits: Unsplash New clinical practice guidelines for tuberculosis (TB) treatment, based on recent clinical trial data, have been issued by the American Thoracic Society (ATS), US CDC, European Respiratory Society (ERS), and the Infectious Diseases Society of America (IDSA). These updates apply to both drug-susceptible and drug-resistant TB in settings with […]

Early Release – Seoul Virus Infection and Subsequent Guillain-Barré Syndrome in Traveler Returning to France from Kenya, 2022 – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Centre Hospitalier Universitaire de Montpellier, Montpellier, France (T.M. Lepage, C. Boullé, V. Le Moing, V. Foulongne); Institut de Recherche pour le Développement, Montpellier (T.M. Lepage, […]

Early Release – Two Human Infections with Diverse Europe-1 Crimean-Congo Hemorrhagic Fever Virus Strains, North Macedonia, 2024 – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Dejan Jakimovski , Kostadin Poposki, Marija Dimzova, Marija Cvetanovska, Fadil Cana, Ivana Bogdan, Alejandro Cabezas-Cruz, Brigitta Zana, Zsófia Lanszki, Zsófia Tauber, Tamás Görföl, Krisztián Bányai, Ágota Ábrahám, Pavle Banović1, […]

Early Release – Acute Encephalopathy Associated with Human Adenovirus Type 14 Infection in 7-Year-Old Girl, Japan – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan (S. Mizuno, Y. Ishida, M. Nishiyama, A. Maruyama, M. Kasai); Kobe Institute of Health, Kobe (Y. Tanimoto, A. […]